Log in
Enquire now
‌

US Patent 11299473 Benzimidazole and indole compounds and uses thereof

Patent 11299473 was granted and assigned to Incyte on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11299473 Benzimidazole and indole compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo